Virus like particles (VLPs) represent tremendous potential as vaccine candidates and the development of therapeutics for infectious diseases. VLPs present significant advantages by mimicking the three-dimentional conformation of an actual virus but are non-infectious because of lacking any viral genome packaged inside the capsid.

AscentGene offers VLP production services using our upgraded baculovirus system throught the self-assembly mechanism. Ascentgene has experienced in producing high titer (4×10¹³vlps/ml), high quality (>99% pure) and high activity VLPs with high yield (2 x 10¹⁴vlps/L culture) by using either CsCl gradient or chromatography protocols.

Available VLP assays:

A) Hemagglutination assay (HA) to analyze VLP’s activity

B) Transmission electron microscope (TEM) to detect VLP’s conformation

C) Enzyme-linked immunosorbent assay (ELISA) to quantify VLP’s titer

D) SDS gel electrophoresis to validate VLP’s quality

E) Western blot to ensure VLP’s specificity

Contact Us for More Information
For additional information or to request a project proposal, please contact us at 1-301-476-0885 or <hge@ascentgene.com>. We will be happy to assist you.